Cite
HARVARD Citation
Mondritzki, T. et al. (2021). Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. European journal of heart failure. pp. 743-750. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mondritzki, T. et al. (2021). Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. European journal of heart failure. pp. 743-750. [Online].